Clinical Trials for GDC-0941

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCBRE1287
09/23/2013
A Phase Ib/II Trial of GDC-0941 (a PI3K inhibitor) in combination with Cisplatin in patients with androgen receptor negative Triple Negative Metastatic Breast Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.